
Krishan Jethwa/mayoclinic.org
Jan 23, 2025, 12:58
Krishan Jethwa discussing the LAPIS trial on locally advanced PDAC
Krishan Jethwa, GI Radiation Oncologist at Mayo Clinic, shared a post on X:
“LAPIS Trial.
Locally advanced PDAC.
Randomized
SoC Systemic therapy (FOLFIRINOX or GnP)
+/-
Pamrevlumab (PAM)
Unfortunately, no improvement in OS, EFS or objective response with addition of PAM.”
More posts featuring Krishan Jethwa.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 1, 2025, 22:02
Mar 1, 2025, 21:59
Mar 1, 2025, 21:56
Mar 1, 2025, 21:12
Mar 1, 2025, 20:56
Mar 1, 2025, 20:45
Mar 1, 2025, 19:57